You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-ERCC2 (ERCC2) Antibodies

Full name:
anti-Excision Repair Cross-Complementing Rodent Repair Deficiency, Complementation Group 2 Antibodies (ERCC2)
On www.antibodies-online.com are 60 Excision Repair Cross-Complementing Rodent Repair Deficiency, Complementation Group 2 (ERCC2) Antibodies from 16 different suppliers available. Additionally we are shipping ERCC2 Proteins (4) and many more products for this protein. A total of 69 ERCC2 products are currently listed.
Synonyms:
AA407812, AU020867, AW240756, CG9433, COFS2, CXPD, DhR3, DhXPD, Dmel\\CG9433, DmXPD, EM9, Ercc-2, ERCC2, l(2)SH2 2137, l(2)SH2137, MGC89573, TTD, xpd, XPD/ERCC2, zgc:56365
list all antibodies Gene Name GeneID UniProt
ERCC2 100361160  
ERCC2 2068 P18074
ERCC2 13871 O08811

Show all species

Show all synonyms

Most Popular Reactivities for anti-ERCC2 (ERCC2) Antibodies

Select your species and application

anti-Rat (Rattus) ERCC2 Antibodies:

anti-Human ERCC2 Antibodies:

anti-Mouse (Murine) ERCC2 Antibodies:

All available anti-ERCC2 Antibodies

Go to our pre-filtered search.

Top referenced anti-ERCC2 Antibodies

  1. Human Polyclonal ERCC2 Primary Antibody for IHC - ABIN966088 : Weber, Salazar, Stewart, Thompson: ERCC2: cDNA cloning and molecular characterization of a human nucleotide excision repair gene with high homology to yeast RAD3. in The EMBO journal 1990 (PubMed)
    Show all 9 references for ABIN966088

  2. Cow (Bovine) Polyclonal ERCC2 Primary Antibody for WB - ABIN2792558 : Braun, Richman, Quirke, Daly, Adlard, Elliott, Barrett, Selby, Meade, Stephens, Parmar, Seymour: Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 (PubMed)

More Antibodies against ERCC2 Interaction Partners

Fruit Fly (Drosophila melanogaster) Excision Repair Cross-Complementing Rodent Repair Deficiency, Complementation Group 2 (ERCC2) interaction partners

  1. XPD expression significantly inhibited HepG2 cell proliferation, promoted HepG2 cell apoptosis, inhibited HepG2 colony formation, decreased HepG2 cells' migratory ability, and significantly lowered HepG2 cells' invasive capacity.

  2. A novel Crb-Galla-Xpd complex and its function for proper chromosome segregation.

  3. The multitask protein Xpd also plays an essential role in cell cycle regulation that appears to be independent of transcription or nucleotide excision repair.

  4. The variant genotypes of XPD Lys751Gln polymorphism are associated with a higher risk of esophageal adenocarcinoma.

Zebrafish Excision Repair Cross-Complementing Rodent Repair Deficiency, Complementation Group 2 (ERCC2) interaction partners

  1. the regulation and expression of XPD

  2. The zebrafish cDNA encoding xpd was isolated and examined its spatial-temporal expression during early development as well as its tissue distribution in adult zebrafish.

Human Excision Repair Cross-Complementing Rodent Repair Deficiency, Complementation Group 2 (ERCC2) interaction partners

  1. The analysis results showed that the following polymorphisms were correlated with susceptibility to lung cancer: rs4646903 in CYP1A1 (show CYP1A1 Antibodies) (P < 0.001), rs1048943 in CYP1A1 (show CYP1A1 Antibodies) (P < 0.001), rs1695 in GSTP1 (show GSTP1 Antibodies) (P < 0.05), rs13181 in ERCC2 (P < 0.001), and rs25487 in XRCC1 (show XRCC1 Antibodies) (P < 0.05); no such correlation existed in rs861539 in XRCC3 (show XRCC3 Antibodies) (P > 0.05).

  2. There was no association between the XPD Lys751Gln polymorphism and CRC (show CALR Antibodies) risk.

  3. Polymorphisms in XPD gene is associated with gastrointestinal stromal tumours.

  4. No association was found between ERCC2 rs13181, and ERCC2 rs1799793 and overall survival of gastric cancer.

  5. Study provides evidence that genetic polymorphisms in XPD-751, XRCC1 (show XRCC1 Antibodies)-194 and XRCC1 (show XRCC1 Antibodies)-399 were all correlated with non-small cell lung cancer occurrence.

  6. the ERCC2 rs13181 polymorphism is correlated with an increased risk of gliomas in codominant and recessive models, which suggests that this polymorphism could influence the etiology of gliomas.

  7. XPD gene polymorphism is associated with acute myeloid leukemia (show BCL11A Antibodies).

  8. The prognostic index comprising XRCC1 (show XRCC1 Antibodies) rs25487, ERCC2 rs13181, and rs1799793 polymorphisms may be a useful predictor of clinical outcomes in MGC treated with EOF.

  9. we conclude that ERCC2 gene polymorphism R156R may be associated with an increased risk of endometrial cancer.

  10. No significant association was found for XPD Asp312Asn polymorphism with the risk of autism spectrum disorder.

Mouse (Murine) Excision Repair Cross-Complementing Rodent Repair Deficiency, Complementation Group 2 (ERCC2) interaction partners

  1. Results describe a recessive cataract caused by a mutation in the Xpd/Ercc2 gene and demonstrate the importance of the gene not only for lens fiber cell differentiation, but also for the sensitivity to ionizing radiation.

  2. Compound TTD (show GTF2H5 Antibodies)/XPCS heterozygosity partially rescues metabolic phenotype associated with homozygous XPD alleles. TTD (show GTF2H5 Antibodies) allele dominates over XPCS allele in measures of UV-sensitivity.

  3. premature aging associated with XPD mutation in mice

  4. Mutations in XPD subunit of TFIIH (show GTF2H4 Antibodies) result in transactivation defect of PPARs in the adipose tissue and the liver.

  5. New pathology features support the premature aging phenotype of Xpd(TTD) mutant mice and further strengthen the link between DNA damage, DNA repair and aging.

  6. XPCS with a G602D-encoding mutation in the Xpd helicase (show DNA2 Antibodies) gene is the most skin cancer-prone NER (show NR1H2 Antibodies) model to date, and it shows an unusual NER (show NR1H2 Antibodies) dysfunction that is likely responsible for this susceptibility

  7. a variety of biallelic effects on organismal phenotype which attributes to combinations of recessive Xpd alleles

  8. results support a general model for premature aging in Xpd DNA repair deficient mice based on cellular responses to DNA damage that impair normal tissue homeostasis

  9. ERCC2 plays role in lung cancer development in a Chinese population.

ERCC2 Antigen Profile

Antigen Summary

The nucleotide excision repair pathway is a mechanism to repair damage to DNA. The protein encoded by this gene is involved in transcription-coupled nucleotide excision repair and is an integral member of the basal transcription factor BTF2/TFIIH complex. The gene product has ATP-dependent DNA helicase activity and belongs to the RAD3/XPD subfamily of helicases. Defects in this gene can result in three different disorders, the cancer-prone syndrome xeroderma pigmentosum complementation group D, trichothiodystrophy, and Cockayne syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Alternative names and synonyms associated with ERCC2

  • excision repair cross-complementing rodent repair deficiency, complementation group 2 (ERCC2) antibody
  • Xeroderma pigmentosum D (Xpd) antibody
  • excision repair cross-complementing rodent repair deficiency, complementation group 2 (ercc2) antibody
  • excision repair cross-complementing rodent repair deficiency, complementation group 2 (LOC100361160) antibody
  • excision repair cross-complementing rodent repair deficiency, complementation group 2 (Ercc2) antibody
  • AA407812 antibody
  • AU020867 antibody
  • AW240756 antibody
  • CG9433 antibody
  • COFS2 antibody
  • CXPD antibody
  • DhR3 antibody
  • DhXPD antibody
  • Dmel\\CG9433 antibody
  • DmXPD antibody
  • EM9 antibody
  • Ercc-2 antibody
  • ERCC2 antibody
  • l(2)SH2 2137 antibody
  • l(2)SH2137 antibody
  • MGC89573 antibody
  • TTD antibody
  • xpd antibody
  • XPD/ERCC2 antibody
  • zgc:56365 antibody

Protein level used designations for ERCC2

DNA-repair protein complementing XP-D cells , excision repair cross-complementing rodent repair deficiency, complementation group 2 (xeroderma pigmentosum D) , CG9433-PA , CG9433-PB , CG9433-PC , Xpd-PA , Xpd-PB , Xpd-PC , lethal (2) SH2137 , xeroderma pigmentosum D , TFIIH basal transcription factor complex helicase subunit , XPD , excision repair cross-complementing rodent repair deficiency, complementation group 2 protein , excision repair cross-complementing rodent repair deficiency, complementation group 2 , excision repair cross-complementing 2 , BTF2 p80 , CXPD , DNA excision repair protein ERCC-2 , DNA repair protein complementing XP-D cells , TFIIH 80 kDa subunit , TFIIH basal transcription factor complex 80 kDa subunit , TFIIH basal transcription factor complex helicase XPD subunit , TFIIH p80 , basic transcription factor 2 80 kDa subunit , xeroderma pigmentosum complementary group D , xeroderma pigmentosum group D-complementing protein , excision repair cross-complementing rodent repair deficiency, complementation group 6-like group 2

GENE ID SPECIES
100049685 Sus scrofa
37414 Drosophila melanogaster
393900 Danio rerio
456124 Pan troglodytes
493493 Xenopus (Silurana) tropicalis
493995 Canis lupus familiaris
100361160 Rattus norvegicus
2068 Homo sapiens
100125238 Bos taurus
13871 Mus musculus
308415 Rattus norvegicus
Selected quality suppliers for anti-ERCC2 (ERCC2) Antibodies
Did you look for something else?